Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

LIFITEGRAST

Brand Name : XIIDRA

Patent Number : 2960117

Filing Date : 2006-05-17

Strength per Unit : 5% w / v

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : OPHTHALMIC

Patent Expiration Date : 2026-05-17

Date Granted : 2018-01-30

blank

02

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

LIFITEGRAST

Brand Name : XIIDRA

Patent Number : 2544678

Filing Date : 2004-11-05

Strength per Unit : 5% w / v

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : OPHTHALMIC

Patent Expiration Date : 2024-11-05

Date Granted : 2013-12-31

blank

03

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

LIFITEGRAST

Brand Name : XIIDRA

Patent Number : 2894170

Filing Date : 2013-12-18

Strength per Unit : 5% w / v

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : OPHTHALMIC

Patent Expiration Date : 2033-12-18

Date Granted : 2021-08-10

blank